Mexiletine Treatment for Neonatal LQT3 Syndrome: Case Report and Literature Review
Background: Early diagnosis of long QT type 3 (LQT3) syndrome during the neonatal period is of paramount clinical importance. LQT3 syndrome results in increased mortality and a mutation-specific response to treatment compared to other more common types of LQT syndrome. Mexiletine, a sodium channel b...
Saved in:
Main Authors: | Alena Bagkaki (Author), Alexandros Tsoutsinos (Author), Eleftheria Hatzidaki (Author), Manolis Tzatzarakis (Author), Fragiskos Parthenakis (Author), Ioannis Germanakis (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Epidemiology of Pediatric Cardiomyopathy in a Mediterranean Population
by: Alena Bagkaki, et al.
Published: (2024) -
Sodium Overload Due To a Persistent Current That Attenuates The Arrhythmogenic Potential of a Novel LQT3 Mutation
by: Adrien eMoreau, et al.
Published: (2013) -
Vicious LQT induced by a combination of factors different from hERG inhibition
by: Xinping Xu, et al.
Published: (2022) -
Mexiletine Differentially Restores the Trafficking Defects Caused by Two Brugada Syndrome Mutations
by: Adrien eMoreau, et al.
Published: (2012) -
Termination of SUNCT with intravenous lignocaine followed by oral mexiletine
by: Eoin Mulroy, et al.
Published: (2018)